Healthcare & Life Sciences
浩博医药AusperBio
Chinaausperbio.com
浩博医药AusperBio is a Healthcare & Life Sciences startup based in China, most recent round Series B.
Activeseries-b
series-b
Stage
About 浩博医药AusperBio
浩博医药AusperBio is a company headquartered in China. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.
AusperBio is a clinical-stage biopharmaceutical company developing antisense oligonucleotide therapeutics primarily targeting hepatitis B virus (HBV) and other diseases such as viral infections, metabolic, genetic, and immune disorders using its proprietary Med-Oligo™ ASO platform.
Explore 浩博医药AusperBio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.